248 related articles for article (PubMed ID: 25301722)
21. Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.
Eisinger DA; Ammer H
J Biol Chem; 2009 Dec; 284(50):34819-28. PubMed ID: 19828455
[TBL] [Abstract][Full Text] [Related]
22. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.
Kong L; Deng Z; Shen H; Zhang Y
Mol Cell Biochem; 2011 Feb; 348(1-2):11-9. PubMed ID: 21052789
[TBL] [Abstract][Full Text] [Related]
23. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
Sutton P; Borgia JA; Bonomi P; Plate JM
Mol Cancer; 2013 Jul; 12():76. PubMed ID: 23866081
[TBL] [Abstract][Full Text] [Related]
24. CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.
Chang CC; Yang MH; Lin BR; Chen ST; Pan SH; Hsiao M; Lai TC; Lin SK; Jeng YM; Chu CY; Chen RH; Yang PC; Chin YE; Kuo ML
Cell Death Differ; 2013 Mar; 20(3):443-55. PubMed ID: 23175185
[TBL] [Abstract][Full Text] [Related]
25. CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies.
Schroeder B; Srivatsan S; Shaw A; Billadeau D; McNiven MA
Mol Biol Cell; 2012 Sep; 23(18):3602-11. PubMed ID: 22833562
[TBL] [Abstract][Full Text] [Related]
26. An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
Xia W; Petricoin EF; Zhao S; Liu L; Osada T; Cheng Q; Wulfkuhle JD; Gwin WR; Yang X; Gallagher RI; Bacus S; Lyerly HK; Spector NL
Breast Cancer Res; 2013; 15(5):R85. PubMed ID: 24044505
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications.
Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ
Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819
[TBL] [Abstract][Full Text] [Related]
28. Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice.
Yu Y; Shintani T; Takeuchi Y; Shirasawa T; Noda M
J Neurosci; 2018 Sep; 38(39):8345-8363. PubMed ID: 30082414
[TBL] [Abstract][Full Text] [Related]
29. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.
Xie G; Peng Z; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1006-15. PubMed ID: 22361730
[TBL] [Abstract][Full Text] [Related]
30. Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs.
Cao C; Lu S; Sowa A; Kivlin R; Amaral A; Chu W; Yang H; Di W; Wan Y
Cancer Lett; 2008 Aug; 266(2):249-62. PubMed ID: 18400375
[TBL] [Abstract][Full Text] [Related]
31. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade.
Andreev J; Galisteo ML; Kranenburg O; Logan SK; Chiu ES; Okigaki M; Cary LA; Moolenaar WH; Schlessinger J
J Biol Chem; 2001 Jun; 276(23):20130-5. PubMed ID: 11274221
[TBL] [Abstract][Full Text] [Related]
32. HGF-independent potentiation of EGFR action by c-Met.
Dulak AM; Gubish CT; Stabile LP; Henry C; Siegfried JM
Oncogene; 2011 Aug; 30(33):3625-35. PubMed ID: 21423210
[TBL] [Abstract][Full Text] [Related]
33. Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors.
Kim Y; Apetri M; Luo B; Settleman JE; Anderson KS
Mol Cancer Res; 2015 Apr; 13(4):765-74. PubMed ID: 25573954
[TBL] [Abstract][Full Text] [Related]
34. Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification.
Yoshida T; Okamoto I; Okamoto W; Hatashita E; Yamada Y; Kuwata K; Nishio K; Fukuoka M; Jänne PA; Nakagawa K
Cancer Sci; 2010 Jan; 101(1):167-72. PubMed ID: 19804422
[TBL] [Abstract][Full Text] [Related]
35. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
Peng Z; Raufman JP; Xie G
PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
[TBL] [Abstract][Full Text] [Related]
36. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
37. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
38. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway.
Chen J; Chen JK; Harris RC
Mol Cell Biol; 2012 Mar; 32(5):981-91. PubMed ID: 22215616
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
